News & Blog

TwoStep Therapeutics Announces Oversubscribed $62.5 Million Series A Financing and FDA Clearance of IND for First-in-Class Peptide-Drug Conjugate

Delivering Large Genetic Payloads With SonoThera’s Ken Greenberg

Synaptiq Therapeutics Launches with Acquisition of Clinical-Stage SYN-001 Program

The mega-round mindset: How biotechs are thinking bigger and raising smarter

GenomeWeb: SonoThera Targets 2027 for First Clinical Trial of Duchenne Gene Therapy

Technical.ly: Temple University spinout’s ‘Goldilocks molecules’ could change how we take our medicine

Longevity.Technology: SonoThera raises $125m to tackle gene therapy limits

BioXconomy: SonaThera raises $125m to advance ultrasound gene therapy platform

GC Therapeutics Appoints Stem Cell Therapy Leader Stefan Irion, MD, as Chief Scientific Officer

MEC in Q1 2026: Introduction to the Medical Excellence Capital Intelligence Platform